Thalidomide-NH-PEG3-COOH
98%
- Product Code: 106469
CAS:
2375283-62-6
| Molecular Weight: | 477.46 g./mol | Molecular Formula: | C₂₂H₂₇N₃O₉ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, away from light, dry, sealed |
Product Description:
Used primarily in the development of targeted drug delivery systems, this compound serves as a linker in bioconjugation strategies. Its structure allows for the attachment of therapeutic agents to targeting molecules, enhancing the precision of drug delivery to specific cells or tissues. This is particularly useful in cancer therapy, where minimizing damage to healthy cells is crucial. Additionally, it is employed in the creation of antibody-drug conjugates (ADCs), which combine the specificity of antibodies with the potency of cytotoxic drugs to effectively treat various malignancies. The PEG (polyethylene glycol) segment improves solubility and stability, reducing the likelihood of immune system recognition and clearance, thereby increasing the therapeutic agent's circulation time in the body.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | ฿72,000.00 |
+
-
|
Thalidomide-NH-PEG3-COOH
Used primarily in the development of targeted drug delivery systems, this compound serves as a linker in bioconjugation strategies. Its structure allows for the attachment of therapeutic agents to targeting molecules, enhancing the precision of drug delivery to specific cells or tissues. This is particularly useful in cancer therapy, where minimizing damage to healthy cells is crucial. Additionally, it is employed in the creation of antibody-drug conjugates (ADCs), which combine the specificity of antibodies with the potency of cytotoxic drugs to effectively treat various malignancies. The PEG (polyethylene glycol) segment improves solubility and stability, reducing the likelihood of immune system recognition and clearance, thereby increasing the therapeutic agent's circulation time in the body.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :